 |
|
Address
Columbia University/NYSPI, 1051 Riverside Drive, Box 123
New York, 10032
Phone:212-923-8862
Fax: 212-543-5913
Email:[email protected]
|
|
|
Education and Training
| PhD
| 1986
| Columbia University
|
| MS
| 1980
| Columbia University
|
| BA
| 1972
| University of California
|
|
|
|
|
Professor of Clinical Epidemiology (in Psychiatry), Mailman School of Public Health
|
and:
Department of Psychiatry, College of Physicians and Surgeons
|
| Dr. Hasin’s research focuses on alcohol and drug disorders and related comorbidity. She has a joint appointment in the Department of Psychiatry at Columbia, is a research scientist at New York State Psychiatric Institute, and has published over 150 papers. Dr. Hasin’s research covers several areas, including gene-environment interaction, nosology (basic conceptions of disorders), factors affecting longitudinal course, and the nature of comorbidity between substance and psychiatric disorders. She is an internationally recognized expert who has participated in World Health Organization studies, recently completed a two-year term as head of the Measurement Group for the national NIDA Clinical Trials Network, and is a current member of the American Psychiatric Association’s DSM-V workgroup on substance use disorders. Dr. Hasin has received extensive research funding from the National Institutes of Health, including three current grants. Studies in Dr. Hasin’s research group include gene-environment interaction in the etiology of alcohol, nicotine and drug use in Israel, novel phenotype development for genetics studies of substance abuse disorders, analyses of national and longitudinal cohort studies of alcohol and drug disorders, and a clinical trial of a technologically enhanced brief drinking-reduction intervention in HIV primary care patients. Dr. Hasin’s diagnostic research instrument, the PRISM, is in use in numerous studies of the relationship of substance and psychiatric disorders.
|
|
|
|
Selected Professional Affiliations |
| ▪
Member, American Psychiatric Assn DSM-V Committee for Substance Use Disorders, 2004 |
| ▪
Member, Genetics Committee, NIDA Clinical Trials Network, 2004 |
| ▪
NIAAA IRG member, Alcohol Epidemiology Review group, 2004 |
| ▪
Advisor/Task Force Member, World Health Organization on Assessment of Alcohol and Drug Use Disorders, International Research, 1990-present |
| ▪
Chairperson, Common Assessment Battery Committee, NIDA Clinical Trials Network, 2003-present |
| ▪
Advisor, Substance Use Workgroup for DSM-IV, 1988-1994, DSM-IV text revisions, 1999 - 2003, APA |
|
| Selected Honors and Awards |
| ▪ NARSAD, Young Investigator Award, 1989 |
| ▪ NIAAA Research Scientist Developmental Award (KO2), 1993-2003 |
| ▪ NIAAA Senior Scientist Award (KO5), 2003-2008 |
|
| Selected Editorial Boards |
| ▪ Assistant Editor, Addiction |
| ▪ Member, Editorial Board, Journal of Studies on Alcohol |
| ▪ Editor in Chief, Journal of Substance Abuse, 1997-2002 |
|
|
Selected New York City Activities |
|
Alcohol Dependence, General Population Validity
Over 6,000 community residents in the New York metropolitan area were originally screened for at-risk drinking in a NIAAA-funded study. 962 of these screened positive and participated in baseline interviews, 809 (87.3% of those still living) were re-interviewed after 10 years. Supplemental funding was provided to study the effects of September 11, 2001 on stress-related drinking. Data analysis is currently underway. This study also involves analysis of national survey data on alcohol and related comorbidity. Study findings have been published in important alcohol journals such as Journal for Studies on Alcohol, Alcoholism: Clinical and Experimental Research, and Drug and Alcohol Dependence.
|
Course of Drug Use Disorders: Effects of Comorbidity
Dr. Hasin is working on a longitudinal study, funded by NIDA was conducted of over 600 patients with alcohol and substance use disorders treated in New York area drug, alcohol, and psychiatric facilities. Study findings on the relationship of substance use and major depression, and the reliability of diagnostic assessment of these conditions for research and clinical purposes have appeared in such major publications as Archives of General Psychiatry and The American Journal of Psychiatry.
|
Reducing Unsafe Drinking in HIV Primary Care
Excess drinking, even if not at alcoholic levels, can ameliorate the effects of anti-retroviral medication and interfere with medication compliance. Therefore, designing effective screening and intervention procedures that can be disseminated to non-research clinical settings has to potential to positively impact the health of HIV primary care patients who are drinking more than they should. A pilot study is currently underway to test proposed procedures.
|
|
|
Selected Global Activities
|
| Alcohol in Israel: Genetic and Environmental Effects
|
Alcohol dependence and heavy drinking are complex traits caused by genetic and environmental factors. This study, funded by the NIAAA will examine the relationship of alcohol metabolizing genes to drinking and alcohol dependence severity, by exposure to different environmental risks (e.g., Russian immigrant status) for drinking. Using the Population Register, 2,550 Israelis will be sampled.
Countries: Israel
|
|
|
|
